1.Effects of fluvastatin on ventricular remodeling and serum TNF-αexpression in elderly patients with acute myocardial infarction
Jianxiang WU ; Chunxin YAN ; Zhenhua FANG
Chinese Journal of Biochemical Pharmaceutics 2017;37(4):397-400
Objective To investigate the effect of fluvastatin on ventricular remodeling and serum tumor necrosis factor alpha(TNF-α)level in elderly patients with acute myocardial infarction.Methods 87 elderly patients with acute myocardial infarction were chosen in Jiande Hospital of Integrated Traditional Chinese and Western Medicine from October 2014 to October 2016,were randomly divided into control group(42 cases)and observation group(45 cases),the control group received aspirin,PI Gray chlorine and other conventional treatment,the observation group were given fluvastatinon the basis of the control group treatment.The changes of cardiac function and serum inflammatory factor TNF-α levels were observed before and after treatment.Results After the treatment,left ventricular weight index such asleft ventricular systolic volume index,left ventricular diastolic membrane membrane volume index,left ventricular ejection fraction in the two groups were improved in different degree,but the observation group improved significantly(P<0.05).In the control group,there was no significant improvement; and after treatment,the indexes of the observation group were significantly better than those of the control group(P<0.05).The effective rate in the observation groupwas 93.33%,was significantly higher than the control group(P<0.05).After treatment,the levels of serum TNF-α were significantly improved in the observation group,and the level of serum was significantly decreased compared with before treatment(P<0.05),and the observation group after the treatment was obviously lower than the control group(P<0.05).Conclusion For elderly patients with acute myocardial infarction with fluvastatin can better improve the patient's heart function,improve the body's inflammatory level,effectively improve the treatment effect,inhibit ventricular remodeling.
2.Compatibility analysis and calculation: treatment of AIDS with Chinese herbal medicine compound
Jinghua LI ; Meng CUI ; Chunxin SONG ; Xianrong WEN ; Hongtao LI ; Yuanbai LI ; Huaiping XI ; Yang YANG ; Lirong JIA ; Lihong LIU ; Yan DONG
International Journal of Traditional Chinese Medicine 2011;33(5):432-435
In China, the treatment of AIDS With Chinese herbal medicine compound has been widely studied and practiced. Clinical Studies showed that the treatment of AIDS with Chinese medicine can significantly relieve AIDS patients' clinical symptoms, improve life quality with rising immunity and alleviate toxic and side effects in antiviral drug. This study took 28 Clinical Studies on the treatment of AIDS with Chinese herbal medicine compound published in Chinese periodicals as the research object, and designed Tree Analysis Algorithm was used to analyze prescription compatibility in the treatment of AIDS with Chinese herbal medicine compound. Results of data analysis revealed that clinical therapy on AIDS could be classified into three types: predominent de-toxication, predominent supplementing Qi, and simultaneous de-toxication and supplementing Qi due to different understanding the pathogenesis of excessive evil and deficient essence-qi. But in practical medication, there has not formed a reasonable and effective combination or basic prescription up to now, except that Astragalus was wildly used.
3.Prenatal diagnosis of spinal muscular atrophy using multiple ligation-dependent probe amplification.
Yan XU ; Junyu ZHANG ; Chunxin CHANG ; Songchang CHEN ; Chenming XU
Chinese Journal of Medical Genetics 2021;38(3):214-218
OBJECTIVE:
To carry out prenatal diagnosis for families with high risk for spinal muscular atrophy (SMA) by using multiplex ligation-dependent probe amplification (MLPA).
METHODS:
Twenty-one families were enrolled. MLPA was used to detect copy numbers of SMN1 and SMN2 genes. Maternal contamination was excluded by using a short tandem repeat method.
RESULTS:
For 23 fetuses from the 21 families, 14 were identified as carriers, 1 as SMA patient, and 8 as normal. By linkage analysis of parental samples, three individuals were determined as silent (2+0) carriers.
CONCLUSION
MLPA can determine the carrier status of SMA. The identification of three silent (2+0) carriers among the 44 parental samples indicated a risk for such families, for which genetic counseling and reproduction guidance should be provided.
Female
;
Genetic Counseling
;
Heterozygote
;
Humans
;
Multiplex Polymerase Chain Reaction
;
Muscular Atrophy, Spinal/genetics*
;
Pregnancy
;
Prenatal Diagnosis
;
Survival of Motor Neuron 1 Protein/genetics*